Elastase-Induced Saccular Aneurysms in Rabbits: A Dose-Escalation Study

References

1. ↵
   Reul J, Weis J, Spetzger U, Konert T, Fricke C, Thoron A. A long-term angiographic and histopathologic findings in experimental aneurysms of the carotid bifurcation embolized with platinum and tungsten coils. AJNR Am J Neuroradiol 1997;18:35–42

   Abstract
2. ↵
   Kallmes DF, Helm GA, Hudson SB, et al. Histologic evaluation of platinum coil embolization in an aneurysm model in rabbits. Radiology 1999;213:217–222

   CrossRefPubMedWeb of Science
3. ↵
   Cloft HJ, Altes TA, Marx WF, et al. Endovascular creation of an in vivo bifurcation aneurysm model in rabbits. Radiology 1999;213:223–228

   PubMedWeb of Science
4. ↵
   Altes TA, Cloft HJ, Short JG, et al. Creation of saccular aneurysms in the rabbit: a model suitable for testing endovascular devices. AJR Am J Roentgenol 2000;174:349–354

   CrossRefPubMedWeb of Science
5. ↵
   Fujiwara NH, Cloft HJ, Marx WF, Short JG, Jensen ME, Kallmes DF. Serial angiography in an elastase-induced aneurysm model in rabbits: evidence for progressive aneurysm enlargement after creation. AJNR Am J Neuroradiol 2001;22:698–703

   Abstract/FREE Full Text
6. ↵
   Halpern VJ, Nackman GB, Gandhi RH, et al. The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. J Vasc Surg 1994;20:51–60

   PubMedWeb of Science
7. ↵
   Curci JA, Petrinec D, Liao S, Golub LM. Thompson RW. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 1998;28:1082–1093

   CrossRefPubMedWeb of Science
8. Moore G, Liao S, Curci JA, et al. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 1999;29:522–532

   CrossRefPubMedWeb of Science
9. Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci 1999;878:159–178

   CrossRefPubMedWeb of Science
10. Treharne GD, Boyle JR, Goodall S, Loftus IM, Bell PR, Thompson MM. Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg 1998;89:431–440
11. Michaelides MR, Curtin ML. Recent advances in matrix metalloproteinase inhibitors research. Curr Pharm Des 1999;5:787–819

    PubMedWeb of Science
12. ↵
    Powell J. Models of arterial aneurysm: for the investigation of pathogenesis and pharmacotherapy—a review. Atherosclerosis 1991;87:93–102

    CrossRefPubMed